PFBT
ALLO icon

Parkside Financial Bank & Trust’s Allogene Therapeutics ALLO Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$388 Hold
159
– – ﹤0.01% 2594
2025
Q4 		$218 Hold
159
– – ﹤0.01% 2635
2025
Q3 		$198 Hold
159
– – ﹤0.01% 2660
2025
Q2 		$180 Sell
159
-285
-64% -$379 ﹤0.01% 2676
2025
Q1 		$649 Buy
444
+285
+179% +$537 ﹤0.01% 2243
2024
Q4 		$339 Hold
159
– – ﹤0.01% 1951
2024
Q3 		$446 Hold
159
– – ﹤0.01% 1856
2024
Q2 		$371 Hold
159
– – ﹤0.01% 1826
2024
Q1 		$711 Hold
159
– – ﹤0.01% 1687
2023
Q4 		$511 Hold
159
– – ﹤0.01% 1747
2023
Q3 		$505 Hold
159
– – ﹤0.01% 1913
2023
Q2 		$791 Hold
159
– – ﹤0.01% 1860
2023
Q1 		$786 Hold
159
– – ﹤0.01% 1863
2022
Q4 		$1K Hold
159
– – ﹤0.01% 1842
2022
Q3 		$2K Hold
159
– – ﹤0.01% 1492
2022
Q2 		$2K Hold
159
– – ﹤0.01% 1521
2022
Q1 		$1K Hold
159
– – ﹤0.01% 1686
2021
Q4 		$2K Hold
159
– – ﹤0.01% 1564
2021
Q3 		$4K Hold
159
– – ﹤0.01% 1298
2021
Q2 		$4K Hold
159
– – ﹤0.01% 1288
2021
Q1 		$6K Buy
+159
New +$5.36K ﹤0.01% 1110

Other funds holding ALLO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parkside Financial Bank & Trust's ALLO Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Allogene Therapeutics (ALLO) position steady in Q1 2026 at 159 shares worth $388. The position accounts for ﹤0.01% of the portfolio, ranked #2594.

Parkside Financial Bank & Trust first reported a position in ALLO in Q1 2021 and has held it in 21 quarters since. The position peaked at $6K in Q1 2021. 209 funds tracked by Wall St. Rank hold ALLO as of Q1 2026.

  • Parkside Financial Bank & Trust held 159 shares of Allogene Therapeutics worth $388 as of Q1 2026.
  • Parkside Financial Bank & Trust left its Allogene Therapeutics share count unchanged in Q1 2026.
  • Allogene Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2594 holding.
  • Parkside Financial Bank & Trust first reported a position in Allogene Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • Parkside Financial Bank & Trust's Allogene Therapeutics position peaked at $6K in Q1 2021.
  • 209 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.